Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-23

Clinical Trial Update: Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients

View source ↗

Summary

This completed clinical trial evaluates the pharmacokinetics of levofloxacin and capreomycin in patients with multidrug-resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capreomycin (Capreomycin)
  • Levofloxacin (Levofloxacin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Tuberculosis | Status: COMPLETED